Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Reichert Life Sciences Collaborates with Ridgeview Instruments AB

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Collaboration to combine Reichert SPR systems with exciting new molecular interaction data analysis software.

Reichert Life Sciences now offers TraceDrawer an advanced molecular interaction data analysis software from Ridgeview Instruments AB for use with our SR7000DC and SR7500DC surface plasmon resonance systems.

Data acquisition with Reichert’s SPRAutolink software and data analysis with Ridgeview’s Tracedrawer software are now fully integrated into one powerful package.

The need for understanding how molecules bind to each other is critical in research and for the development of drugs and therapeutic antibodies.

The collaboration between Reichert Life Sciences and Ridgeview Instruments AB, Uppsala Sweden, provides distinct advantages to customers by combining data acquisition software and data analysis software into one integrated SPR system for use in all research and development laboratories.

TraceDrawer data analysis software is used for data fitting and to summarize results obtained for a wide variety of biomolecular interactions.

TraceDrawer and SPRAutolink are fully linked together. Just one click from the Post-Processing screen in SPRAutolink automatically transfers your data directly to Tracedrawer for analysis, thus eliminating the need to manually export data to an external data analysis program. This integration enables efficient and cost-effective analyses of molecular interactions.

Thomas E. Ryan, Chief Scientist of Reichert Technologies Life Sciences said: “TraceDrawer brings a new level of sophistication to Reichert Technologies Surface Plasmon Resonance Systems. Data analysis and reporting is now seamlessly integrated into Reichert’s “Autolink” instrument operation and data collection software. The software features excellent data fitting algorithms, numerous kinetic models, the capability to combine data sets from many experiments or surfaces and numerous reporting options. Our partners at Ridgeview Instruments have created a world class data analysis package.”

Dr. Karl Andersson, CEO of Ridgeview Instruments AB said: “We are pleased to see that TraceDrawer, our multi-purpose evaluation platform for advanced molecular interaction analysis, is implemented in Reichert Technologies Life Sciences SPR systems. I am convinced that TraceDrawer will make the customers of Reichert Technologies more productive through better understanding of their molecules leading to faster decisions. For Ridgeview Instruments AB, this collaboration is yet another proof that the open innovation philosophy of TraceDrawer is a winning concept that brings significant value both to instrument vendors and the scientific community on a global scale.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Wednesday, November 18, 2015
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos